Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1449427
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1449427
Antisense and RNAi Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Technology (Antisense RNA and RNA Interference); By Route of Administration; By Application; By Region; Segment Forecast, 2024 - 2032
PUBLISHED:
PAGES: 115 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global antisense and RNAi therapeutics market size is expected to reach USD 18.43 billion by 2032, according to a new study by Polaris Market Research. The report "Antisense and RNAi Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Technology (Antisense RNA and RNA Interference); By Route of Administration; By Application; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global market for antisense and RNAi therapeutics has seen significant growth due to advancements in RNA-based drug development and improved understanding of disease mechanisms. These technologies are now being explored for new indications beyond their current uses, with many pipeline drugs targeting conditions with limited treatment options. Neurodegenerative disorders, such as Alzheimer's and Huntington's, are particularly challenging to treat, but emerging research suggests that RNA interference could offer new possibilities for addressing these conditions.
The expanding trend of multidisciplinary development approaches is having a substantial impact on the global market for antisense and RNAi therapies. Traditionally, preclinical and clinical research, regulatory affairs, and discovery were all conducted in distinct silos during the drug development process. Currently, nevertheless, there is a movement toward more integrated, interdisciplinary models that combine several fields of knowledge throughout the whole drug development life cycle.
RNAi and antisense medicines, which pose special technical obstacles, are benefiting from this comprehensive, cooperative approach. These nucleic acid-based medications necessitate input from a broad range of scientific disciplines, including molecular biology, biochemistry, pharmacology, and clinical medicine, due to their very mechanism of action. These specialist skill sets can work in multidisciplinary teams to progress antisense and RNAi candidates more efficiently as a group.
Untapped emerging markets offer significant growth opportunities for the global antisense and RNAi therapeutics market. Many developing countries have large numbers of patients suffering from life-threatening diseases, but they face limited or unavailable treatment options due to poor healthcare infrastructure and lack of access. Antisense and RNAi therapeutics have the potential to greatly improve patient outcomes in these countries by providing targeted treatments that are cost-effective and have fewer side effects than traditional drugs. This could expand access to essential medicines and facilitate the development of affordable new therapies for major diseases such as cancer, cardiovascular diseases, and hepatitis C, which have high mortality rates in these regions. Addressing the substantial unmet medical needs of underserved populations in these regions could be a driving force for market growth.
Antisense and RNAi Therapeutics Market Report Highlights
The antisense RNA segment dominated the market in 2023, driven by conducting tests on it to regulate various conditions.
The intrathecal injections segment led the market in 2023 and is expected to maintain its dominance due to its application in pain management and introduction of medications to fight particular infections.
North America holds a significant revenue share in the global antisense and RNAi therapeutics market, driven by major biopharmaceutical companies and heavy investment made by them in activities such as research and development.
The global key market players include Alynylam Pharmaceuticals, Inc., Arbutus Biopharma, Benitec Biopharma, Inc., GSK plc, Ionois Pharmaceuticals, Inc., Olix Pharmaceuticals, and Sanofi.
Polaris Market Research has segmented the Antisense and RNAi therapeutics market report based on technology, route of administration, application, and region:
Antisense and RNAi therapeutics, Technology Outlook (Revenue - USD Billion, 2019 - 2032)
- Antisense RNA
- RNA Interference
- Others
Antisense and RNAi therapeutics, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)
- Intrathecal Injections
- Subcutaneous Injections
- Intravenous Injections
- Other Delivery Methods
Antisense and RNAi therapeutics, Application Outlook (Revenue - USD Billion, 2019 - 2032)
- Neurodegenerative Disorders
- Genetic Disease
- Cancer
- Cardiometabolic & Renal Disorders
- Infectious Disease
- Skin Disorders
- Respiratory Disorders
- Ocular Disorders
Antisense and RNAi therapeutics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Australia
- Rest of Asia Pacific
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of Middle East & Africa
Product Code: PM4641
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Antisense and RNAi Therapeutics Market Insights
- 4.1. Antisense and RNAi Therapeutics Market - Application Snapshot
- 4.2. Antisense and RNAi Therapeutics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising focus on orphan and rare indications
- 4.2.1.2. Advancement in methods of delivering drugs
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Challenges associated with the delivery of RNA Therapeutics
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Antisense and RNAi Therapeutics Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Antisense and RNAi Therapeutics Market, by Route of Administration
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 5.3. Intrathecal Injections
- 5.3.1. Global Antisense and RNAi Therapeutics Market, by Intrathecal Injections, by Region, 2019-2032 (USD Billion)
- 5.4. Subcutaneous Injections
- 5.4.1. Global Antisense and RNAi Therapeutics Market, by Subcutaneous Injections, by Region, 2019-2032 (USD Billion)
- 5.5. Intravenous Injections
- 5.5.1. Global Antisense and RNAi Therapeutics Market, by Intravenous Injections, by Region, 2019-2032 (USD Billion)
- 5.6. Other Delivery Methods
- 5.6.1. Global Antisense and RNAi Therapeutics Market, by Other Delivery Methods, by Region, 2019-2032 (USD Billion)
6. Global Antisense and RNAi Therapeutics Market, by Technology
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 6.3. Antisense RNA
- 6.3.1. Global Antisense and RNAi Therapeutics Market, by Antisense RNA, by Region, 2019-2032 (USD Billion)
- 6.4. RNA Interference
- 6.4.1. Global Antisense and RNAi Therapeutics Market, by RNA Interference, by Region, 2019-2032 (USD Billion)
- 6.5. Others
- 6.5.1. Global Antisense and RNAi Therapeutics Market, by Others, by Region, 2019-2032 (USD Billion)
7. Global Antisense and RNAi Therapeutics Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 7.3. Neurodegenerative Disorders
- 7.3.1. Global Antisense and RNAi Therapeutics Market, by Neurodegenerative Disorders, By Region, 2019-2032 (USD Billion)
- 7.4. Genetic Disease
- 7.4.1. Global Antisense and RNAi Therapeutics Market, by Genetic Disease, By Region, 2019-2032 (USD Billion)
- 7.5. Cancer
- 7.5.1. Global Antisense and RNAi Therapeutics Market, by Cancer, By Region, 2019-2032 (USD Billion)
- 7.6. Cardiometabolic & Renal Disorders
- 7.6.1. Global Antisense and RNAi Therapeutics Market, by Cardiometabolic & Renal Disorders, By Region, 2019-2032 (USD Billion)
- 7.7. Infectious Disease
- 7.7.1. Global Antisense and RNAi Therapeutics Market, by Infectious Disease, By Region, 2019-2032 (USD Billion)
- 7.8. Skin Disorders
- 7.8.1. Global Antisense and RNAi Therapeutics Market, by Skin Disorders, By Region, 2019-2032 (USD Billion)
- 7.9. Respiratory Disorders
- 7.9.1. Global Antisense and RNAi Therapeutics Market, by Respiratory Disorders, By Region, 2019-2032 (USD Billion)
- 7.10. Ocular Disorders
- 7.10.1. Global Antisense and RNAi Therapeutics Market, by Ocular Disorders, By Region, 2019-2032 (USD Billion)
8. Global Antisense and RNAi Therapeutics Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Antisense and RNAi Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Antisense and RNAi Therapeutics Market - North America
- 8.3.1. North America: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.3.2. North America: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.3.3. North America: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.3.4. Antisense and RNAi Therapeutics Market - U.S.
- 8.3.4.1. U.S.: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.3.5. Antisense and RNAi Therapeutics Market - Canada
- 8.3.5.1. Canada: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.4. Antisense and RNAi Therapeutics Market - Europe
- 8.4.1. Europe: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.4.3. Europe: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.4.4. Antisense and RNAi Therapeutics Market - UK
- 8.4.4.1. UK: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.4.5. Antisense and RNAi Therapeutics Market - France
- 8.4.5.1. France: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.4.5.3. France: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.4.6. Antisense and RNAi Therapeutics Market - Germany
- 8.4.6.1. Germany: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.4.7. Antisense and RNAi Therapeutics Market - Italy
- 8.4.7.1. Italy: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.4.8. Antisense and RNAi Therapeutics Market - Spain
- 8.4.8.1. Spain: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.4.9. Antisense and RNAi Therapeutics Market - Netherlands
- 8.4.9.1. Netherlands: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.4.10. Antisense and RNAi Therapeutics Market - Russia
- 8.4.10.1. Russia: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.5. Antisense and RNAi Therapeutics Market - Asia Pacific
- 8.5.1. Asia Pacific: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.5.4. Antisense and RNAi Therapeutics Market - China
- 8.5.4.1. China: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.5.4.3. China: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.5.5. Antisense and RNAi Therapeutics Market - India
- 8.5.5.1. India: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.5.5.3. India: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.5.6. Antisense and RNAi Therapeutics Market - Malaysia
- 8.5.6.1. Malaysia: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.5.7. Antisense and RNAi Therapeutics Market - Japan
- 8.5.7.1. Japan: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.5.8. Antisense and RNAi Therapeutics Market - Indonesia
- 8.5.8.1. Indonesia: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.5.9. Antisense and RNAi Therapeutics Market - South Korea
- 8.5.9.1. South Korea: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.6. Antisense and RNAi Therapeutics Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.6.4. Antisense and RNAi Therapeutics Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.6.5. Antisense and RNAi Therapeutics Market - UAE
- 8.6.5.1. UAE: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.6.6. Antisense and RNAi Therapeutics Market - Israel
- 8.6.6.1. Israel: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.6.7. Antisense and RNAi Therapeutics Market - South Africa
- 8.6.7.1. South Africa: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.7. Antisense and RNAi Therapeutics Market - Latin America
- 8.7.1. Latin America: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.7.4. Antisense and RNAi Therapeutics Market - Mexico
- 8.7.4.1. Mexico: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.7.5. Antisense and RNAi Therapeutics Market - Brazil
- 8.7.5.1. Brazil: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- 8.7.6. Antisense and RNAi Therapeutics Market - Argentina
- 8.7.6.1. Argentina: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Alnylam Pharmaceuticals, Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Arbutus Biopharma
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Benitec Biopharma Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. GSK plc
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Ionis Pharmaceuticals, Inc
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Olix Pharmaceuticals, Inc
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Percheron Therapeutics Limited
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Sanofi
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Sarepta Therapeutics
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Silence Therapeutics
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
Product Code: PM4641
List of Tables
- Table 1 Global Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 2 Global Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 3 Global Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 4 Antisense and RNAi Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
- Table 5 North America: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 6 North America: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 7 North America: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 8 U.S.: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 9 U.S.: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 10 U.S.: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 11 Canada: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 12 Canada: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 13 Canada: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 14 Europe: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 15 Europe: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 16 Europe: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 17 UK: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 18 UK: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 19 UK: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 20 France: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 21 France: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 22 France: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 23 Germany: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 24 Germany: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 25 Germany: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 26 Italy: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 27 Italy: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 28 Italy: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 29 Spain: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 30 Spain: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 31 Spain: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 32 Netherlands: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 33 Netherlands: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 34 Netherlands: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 35 Russia: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 36 Russia: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 37 Russia: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 38 Asia Pacific: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 39 Asia Pacific: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 40 Asia Pacific: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 41 China: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 42 China: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 43 China: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 44 India: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 45 India: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 46 India: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 47 Malaysia: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 48 Malaysia: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 49 Malaysia: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 50 Japan: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 51 Japan: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 52 Japan: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 53 Indonesia: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 54 Indonesia: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 55 Indonesia: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 56 South Korea: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 57 South Korea: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 58 South Korea: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 59 Middle East & Africa: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 60 Middle East & Africa: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 61 Middle East & Africa: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 62 Saudi Arabia: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 63 Saudi Arabia: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 64 Saudi Arabia: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 65 UAE: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 66 UAE: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 67 UAE: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 68 Israel: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 69 Israel: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 70 Israel: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 71 South Africa: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 72 South Africa: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 73 South Africa: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 74 Latin America: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 75 Latin America: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 76 Latin America: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 77 Mexico: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 78 Mexico: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 79 Mexico: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 80 Brazil: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 81 Brazil: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 82 Brazil: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
- Table 83 Argentina: Antisense and RNAi Therapeutics Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 84 Argentina: Antisense and RNAi Therapeutics Market, by Technology, 2019-2032 (USD Billion)
- Table 85 Argentina: Antisense and RNAi Therapeutics Market, by Application, 2019-2032 (USD Billion)
List of Figures
- Figure 1. Global Antisense and RNAi Therapeutics Market, 2019-2032 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Technology
- Figure 7. Global Antisense and RNAi Therapeutics Market, by Technology, 2022 & 2032 (USD Billion)
- Figure 8. Market by Route of Administration
- Figure 9. Global Antisense and RNAi Therapeutics Market, by Route of Administration, 2022 & 2032 (USD Billion)
- Figure 10. Market by Application
- Figure 11. Global Antisense and RNAi Therapeutics Market, by Application, 2022 & 2032 (USD Billion)
- Figure 12. Antisense and RNAi Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
- Figure 13. Strategic Analysis - Antisense and RNAi Therapeutics Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.